Descriptor: "Peptide Hormones" / Publication Type: Magazines - Searchworks@Jio Institute Digital Library Search Results

Subjects: MALE reproductive organs, PITUITARY gland, PEPTIDE hormones, FERTILIZATION (Biology), THYROID hormones, OVARIAN follicle, GENETIC translation, SEX hormones, ENDOCRINE glands
Abstract: The article provides an in-depth exploration of the endocrine system, detailing the functions and classifications of various glands and hormones. It also discusses the types of glands (exocrine and endocrine), the properties of hormones, and specific endocrine disorders affecting the pituitary, thyroid, parathyroid, adrenal glands, pancreas, and gonads.
Published: 2024

Author: Lesté-Lasserre, Christa
Subjects: *ERYTHROCYTES, *PEPTIDE hormones, *DOPING agents (Chemistry), *HAIR analysis, *PERFORMANCE-enhancing drugs
Abstract: The article discusses the measures in place to catch athletes who use performance-enhancing drugs at the 2024 Paris Olympics. The World Anti-Doping Agency (WADA) develops and coordinates anti-doping rules and policies and publishes updated lists of prohibited substances. The most commonly detected substances are anabolic steroids and diuretics. WADA stays at the forefront of new substances and methods through collaboration with the pharmaceutical industry and stores samples for 10 years for further analysis. The athlete biological passport and software analyses are used to detect changes in samples over time. WADA is also working on developing detection methods for gene doping. The use of carbon monoxide inhalation to enhance performance is a concern, but there is no consensus on its effectiveness. WADA primarily uses urine samples for testing, but some experts suggest including hair and nail analyses for a longer-term picture. However, WADA has not included these analyses in its policy at this time. [Extracted from the article]
Published: 2024

Subjects: GONADS, PITUITARY gland, AFFERENT pathways, SOMATOSTATIN, PEPTIDE hormones, GROWTH hormone releasing factor, ENDOCRINE system, SODIUM channels, PROSTAGLANDIN receptors
Abstract: The article provides information on neural control and coordination in the neural system and chemical coordination and integration of hormones in the endocrine system. Topics discussed include categories of the neural system, structural parts of the neuron and their functions, generation and conduction of nerve impulse, transmission through synapse, types of synapse, central neural system, types of glands, hormones of heart, kidney and gastrointestinal tract, and mechanism of hormone action.
Published: 2024

Author: Rinaldi, Jamie
Subjects: REDUCING diets, FOOD habits, ENERGY metabolism, APPETITE, BODY weight, SKELETAL muscle, FOOD consumption, LEAN body mass, GLUCAGON-like peptide 1, GUT microbiome, CONTINUING education units, BASAL metabolism, HUNGER, STARVATION, PHYSIOLOGICAL adaptation, PHYSICAL activity, WEIGHT gain, INTERMITTENT fasting, FAT cells, WEIGHT loss, HIGH-protein diet, BODY temperature regulation, PEPTIDE hormones, TRIIODOTHYRONINE, EXERCISE therapy, ADIPOSE tissues, HYDROCORTISONE, EATING disorders, DIETARY patterns, DISEASE complications
Published: 2024

Subjects: *BLOOD pressure, *DRUG efficacy, *VENTRICULAR ejection fraction, *HEMATOCRIT, *BLOOD plasma, *PULMONARY artery, *RELAXATION for health, *DAPAGLIFLOZIN, *EXERCISE, *WEIGHT loss, *HEMODYNAMICS, *BLOOD volume, *PEPTIDE hormones, *HEART failure, *PHARMACODYNAMICS, *EVALUATION, *SYMPTOMS
Abstract: The article informs about a study on the hemodynamic effects of the SGLT2 inhibitor dapagliflozin in patients with heart failure with preserved ejection fraction (HFpEF). Topic include the study suggests that dapagliflozin reduces pulmonary capillary wedge pressure (PCW) at rest and during exercise, providing insights into potential mechanisms underlying the observed reduction in heart failure hospitalizations or cardiovascular death in larger trials.
Published: 2023